J&J’s Sedasys Sedation Device Heads To FDA Appeals Panel Dec. 14
This article was originally published in The Gray Sheet
Executive Summary
FDA’s Medical Devices Dispute Resolution Panel will vote Dec. 14 on the merits of the agency’s 2010 decision to deny PMA approval for Ethicon Endo-Surgery’s Sedasys computer-assisted personalized sedation system.
You may also be interested in...
Regulatory News In Brief
A round-up of regulatory news affecting the medical device industry.
J&J Gets Second Chance At Sedasys Sedation Device Approval
Johnson & Johnson subsidiary Ethicon Endo-Surgery has received a go-ahead from the FDA commissioner's office to embark on a rarely used process to appeal a PMA denial by the agency’s device center.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”